Aortic valve replacement in patients with preexisting liver disease: Transfemoral approach with favorable survival.
Philipp Christian SeppeltJessica ZappelHelge WeilerSilvia Mas-PeiróNestoras PapadopoulosThomas WaltherAndreas Michael ZeiherStephan FichtlschererMariuca Vasa-NicoteraPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)
Our results indicate increased perioperative risks for patients with liver disease undergoing AVR, but favorable long-term survival after TF-TAVR compared to SAVR. For baseline risk, stratification in patients with liver disease undergoing AVR, MELD-Na and STS-PROMM are valuable predictors.